Please assess the completion status of the following clinical trial:

Trial Title: Detection of Arousal With Facial Micro-expression in Severe Brain-damaged Patient

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Brain-damaged patient (stroke, traumatic brain injury, anoxia)~* Disorder of consciousness (CRS-R≤ 10) more than 48h after stopping sedation~* Patient without spontaneous or stimulated facial expressions~Exclusion Criteria:~* Medically unstable patient

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Severe brain-damaged patient in coma awakening (Type: EXPERIMENTAL): For each patient, video sessions of the face will be performed during a waking period, until the spontaneous macro-EFE (Emotional Facial Expression) reappears. The video sessions will be done without stimulation or with visual, auditory or tactile stimulation. The sessions will be daily for 7 days then weekly for a maximum duration of 4 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).